Skip to content

A study of the safety and efficacy of hybridization surgery for the treatment of patients with nonthrombotic iliac vein compression syndrome combined with deep venous valve insufficiency

A study of the safety and efficacy of hybridization surgery for the treatment of patients with nonthrombotic iliac vein compression syndrome combined with deep venous valve insufficiency

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100824
Enrollment
Unknown
Registered
2025-04-15
Start date
2024-03-01
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Extremity Venous Diseases

Interventions

experimental group:Simultaneous management of iliac vein endovenous stent placement + superficial lower extremity venous therapy
control group:Iliac vein stenting alone

Sponsors

Beijing Luhe Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (1) Age 20-70 years; (2) Patients with imaging studies showing iliac vein compression >50% or with the establishment of collateral circulation around the iliac vein; pressure gradient of the stenotic segment measured during venography >2 mmHg at rest; (3) Imaging examinations suggesting tortuous dilatation of the superficial vein and its side branches, saphenous femoral vein valve regurgitation time of >3s, superficial femoral vein valve regurgitation time of >0.5s; retrograde imaging through the femoral vein showed that the results were graded by the Kistner grading method, and the venous blood regurgitation were all in grade III or above; (4) Voluntary consent to enroll in the study, good compliance with diagnosis and treatment, and the ability to accurately describe the contents of the scoring.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) Patients with a combination of other diseases manifesting as elevated venous pressure in the lower extremities; (2) Patients who are unable to tolerate the surgery in combination with severe hepatic or renal insufficiency, or cardiopulmonary insufficiency, or malignant tumor diseases; (3) patients with sequelae of deep vein thrombosis, iliac vein stenosis and deep vein thrombosis found by lower extremity venography; (4) Patients with poor compliance, or allergy to contrast agent or contraindication to anticoagulation; (5) Patients with severe mental illness.

Design outcomes

Primary

MeasureTime frame
Lower extremity venous disease severity score;Quality of life scores;

Secondary

MeasureTime frame
Iliac vein patency;

Countries

China

Contacts

Public ContactWu Yingfeng

Beijing Luhe Hospital, Capital Medical University

wyfxgwk@163.com+86 178 6519 8281

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026